XML 35 R21.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Derivative Financial Instruments | 12 Months Ended
--- | ---
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Financial Instruments | Derivative Financial Instruments The following table presents the fair value and notional amount of our derivative financial instruments at December 31, 2021 and 2020. Table 11.1 – Fair Value and Notional Amount of Derivative Financial Instruments
|  | December 31, 2021 |  | December 31, 2020
|  | Fair Value |  | Notional Amount |  | Fair Value |  | Notional Amount
(In Thousands) |  |  |  |
Assets - Risk Management Derivatives |  |  |  |  |  |  |  |
Interest rate swaps |  | $ | 611 |  |  | $ | 161,500 |  |  | $ | 224 |  |  | $ | 42,000 |
TBAs |  | 2,880 |  |  | 2,440,000 |  |  | 18,260 |  |  | 3,520,000 |
Interest rate futures |  | 25 |  |  | 9,000 |  |  | — |  |  | — |
Swaptions |  | 18,318 |  |  | 1,660,000 |  |  | 19,727 |  |  | 1,585,000 |
Assets - Other Derivatives |  |  |  |  |  |  |  |
Loan purchase and interest rate lock commitments |  | 4,633 |  |  | 971,631 |  |  | 15,027 |  |  | 2,617,254 |
Total Assets |  | $ | 26,467 |  |  | $ | 5,242,131 |  |  | $ | 53,238 |  |  | $ | 7,764,254 |
Liabilities - Risk Management Derivatives |  |  |  |  |  |  |  |
Interest rate swaps |  | (1,251) |  |  | 283,100 |  |  | — |  |  | — |
TBAs |  | (658) |  |  | 870,000 |  |  | (15,495) |  |  | 3,105,000 |
Interest rate futures |  | (905) |  |  | 62,500 |  |  | — |  |  | — |
Liabilities - Other Derivatives |  |  |  |  |  |  |  |
Loan purchase commitments |  | (503) |  |  | 404,190 |  |  | (577) |  |  | 477,153 |
Total Liabilities |  | $ | (3,317) |  |  | $ | 1,619,790 |  |  | $ | (16,072) |  |  | $ | 3,582,153 |
Total Derivative Financial Instruments, Net |  | $ | 23,150 |  |  | $ | 6,861,921 |  |  | $ | 37,166 |  |  | $ | 11,346,407 |
Risk Management Derivatives To manage, to varying degrees, risks associated with certain assets and liabilities on our consolidated balance sheets, we may enter into derivative contracts. At December 31, 2021, we were party to swaps and swaptions with an aggregate notional amount of $2.10 billion, futures with an aggregate notional amount of $72 million and TBA agreements with an aggregate notional amount of $3.31 billion. At December 31, 2020, we were party to swaps and swaptions with an aggregate notional amount of $1.63 billion, and TBA agreements with an aggregate notional amount of $6.63 billion. For the years ended December 31, 2021, 2020, and 2019, risk management derivatives had a net market valuation gain of $41 million, a net market valuation loss of $93 million, and a net market valuation loss of $134 million, respectively. These market valuation gains and losses are recorded in Mortgage banking activities, net, Investment fair value changes, net and Other income on our consolidated statements of income (loss). Loan Purchase and Interest Rate Lock Commitments LPCs and IRLCs that qualify as derivatives are recorded at their estimated fair values. For the years ended December 31, 2021, 2020, and 2019, LPCs and IRLCs had a net market valuation gain of $11 million, a net market valuation gain of $57 million, and a net market valuation gain of $62 million, respectively, that were recorded in Mortgage banking activities, net on our consolidated statements of income (loss). Derivatives Designated as Cash Flow Hedges To manage the variability in interest expense related to portions of our long-term debt, we designated certain interest rate swaps as cash flow hedges. During the first quarter of 2020, we terminated and settled all of our outstanding derivatives that had been designated as cash flow hedges for our trust preferred securities and subordinated debt, with a payment of $84 million. For interest rate agreements previously designated as cash flow hedges, our total unrealized loss reported in Accumulated other comprehensive income was $76 million and $81 million at December 31, 2021 and 2020, respectively. We will amortize this loss into interest expense over the remaining term of our trust preferred securities and subordinated notes. As of December 31, 2021, we expect to amortize $4 million of realized losses related to terminated cash flow hedges into interest expense over the next twelve months. For the years ended December 31, 2021, 2020, and 2019, changes in the values of designated cash flow hedges were $0, negative $33 million, and negative $17 million, respectively, and were recorded in Accumulated other comprehensive income, a component of equity. The following table illustrates the impact on interest expense of our interest rate agreements accounted for as cash flow hedges for the years ended December 31, 2021, 2020, and 2019. Table 11.2 – Impact on Interest Expense of Interest Rate Agreements Accounted for as Cash Flow Hedges
|  | Years Ended December 31,
(In Thousands) |  | 2021 |  | 2020 |  | 2019
Net interest expense on cash flows hedges |  | $ | — |  |  | $ | (860) |  |  | $ | (2,847) |
Realized net losses reclassified from other comprehensive income |  | (4,127) |  |  | (3,188) |  |  | — |
Total Interest Expense |  | $ | (4,127) |  |  | $ | (4,048) |  |  | $ | (2,847) |
Derivative Counterparty Credit Risk We incur credit risk to the extent that counterparties to our derivative financial instruments do not perform their obligations under specified contractual agreements. If a derivative counterparty does not perform, we may not receive the proceeds to which we may be entitled under these agreements. Each of our derivative counterparties that is not a clearinghouse must maintain compliance with International Swaps and Derivatives Association (“ISDA”) agreements or other similar agreements (or receive a waiver of non-compliance after a specific assessment) in order to conduct derivative transactions with us. Additionally, we review non-clearinghouse derivative counterparty credit standings, and in the case of a deterioration of creditworthiness, appropriate remedial action is taken. To further mitigate counterparty risk, we exit derivatives contracts with counterparties that (i) do not maintain compliance with (or obtain a waiver from) the terms of their ISDA or other agreements with us; or (ii) do not meet internally established guidelines regarding creditworthiness. Our ISDA and similar agreements currently require full bilateral collateralization of unrealized loss exposures with our derivative counterparties. Through a margin posting process, our positions are revalued with counterparties each business day and cash margin is generally transferred to either us or our derivative counterparties as collateral based upon the directional changes in fair value of the positions. We also attempt to transact with several different counterparties in order to reduce our specific counterparty exposure. With respect to certain of our derivatives, clearing and settlement is through one or more clearinghouses, which may be substituted as a counterparty. Clearing and settlement of derivative transactions through a clearinghouse is also intended to reduce specific counterparty exposure. We consider counterparty risk as part of our fair value assessments of all derivative financial instruments at each quarter-end. At December 31, 2021, we assessed this risk as remote and did not record a specific valuation adjustment. At December 31, 2021, we were in compliance with our derivative counterparty ISDA agreements.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 5 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration